Facebook
Twitter
LinkedIn
ForwardEmerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2024 - EXHIBIT REGISTRATION
EXHIBITOR/SPONSOR REGISTRATION
You are NOT confirmed to exhibit until you register.
Registration deadline: September 13, 2024
Dear Corporate Partner,
It is our pleasure to invite you to exhibit at our Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2024 hosted at the Houston Methodist Research Institute on Saturday, September 21, 2024. On behalf of our Course Director, Dr. Victor Ankoma-Sey, and the Office of Continuing Medical Education (CME) we graciously extend the opportunity for you to join us as an exhibitor and/or sponsor!
We estimate that this annual conference will attract approximately 100 to 150 in-person attendees and virtual attendees – all potential customers for your products and services.
I encourage you to take full advantage of this excellent opportunity to network with your target market as an exhibitor. Exhibiting companies will have the opportunity to share their educational materials and interact with participants.
Due to our limited number of exhibit openings, we hope you will take this opportunity and contact us now to register.
Please feel free to contact [email protected] if you have any questions or need additional information.
Sincerely,
Victor Ankoma-Sey, MD, FACP, FAASLD
Director, Liver Associates of Texas, PA
Director, Liver Transplant Program
Sherrie and Alan Conover Center for Liver
Disease & Transplantation and
Houston Methodist J.C. Walter Jr. Transplant Center
EXHIBIT DETAILS
Date and Time
Saturday, September 21, 2024 | 7:00am – 5:00pm
Exhibit Location
Houston Methodist Research Institute
6670 Bertner Ave.
2nd Floor Pre-Function Space
Houston, TX 77030
EXHIBIT FEE: $1,500
- One 6’ x 3’ table-top exhibit with two chairs
- Exhibiting companies may send a maximum of two (2) representatives to staff their exhibit table.
- Recognition in the webpage and activity materials
SPONSORSHIP OPTIONS:
• BREAK SPONSORSHIP: $2,400 – Recognition in activity materials and signage during breaks as Break Sponsor
• BREAKFAST SPONSORSHIP: $3,600– Recognition in activity materials and signage during breakfast as Breakfast Sponsor
• LUNCH SPONSORSHIP: $6,000 – Recognition in activity materials and signage during lunch as Lunch Sponsor
• LUNCH PRODUCT THEATER (1 slot available): $7,000 - Product Theatre is a 30-minute lunch time slot for a company-provided expert to feature your products and services! Product theater located adjacent to educational space.
NOTE: Companies may purchase one exhibit and one sponsorship only.
Target Audience
Hepatologists, Oncologists, Internal Medicine, Internists, Primary Care Physicians, Abdominal Surgeons, Social Workers, Transplant Coordinators, Nutritionists, Nurses, Nurse Practitioners, Physician Assistants, and Residents/Fellows will benefit from this course.
Learning Objectives
- Discuss the current trends in Liver Disease.
- Describe new and critical developments in chronic HBV, HCV and HDV.
- Identify emerging trends in the obesity crisis & nonalcoholic fatty liver disease and explore the latest concepts in diagnosis and management.
- Discuss new developments and treatment of liver and pancreatic cancers – an emerging epidemic.
| Emerging Topics in Liver Disease Conference | ||
| AGENDA | Saturday, September 21 | ||
| TIME | PRESENTATION | SPEAKER(S) |
| 7:00 AM | Registration and Breakfast | |
| 7:30 AM | Welcome | Victor Ankoma-Sey, MD |
| 7:35 AM | Introductory Remarks | R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed) |
| PLENARY SESSION I Alcoholic Liver Disease - An Update Moderators: Joseph Galati, MD, Chukwuma Egwim, MD & Ashish Saharia, MD | ||
| 7:40 AM | Alcohol Use Disorder and Alcohol Associated Liver Disease - Evolving Definitions, Diagnosis & Epidemiology | Ashwani K. Singal, MD |
| 8:10 AM | State of the Art Lecture I Alcohol Associated Liver Disease: Current & Future Therapies | Ramon Bataller, MD |
| 8:40 AM | Alcohol Associated Liver Disease & Liver Transplantation | R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed) |
| 9:05 AM | Q&A and Discussion | |
| 9:20 AM | BREAK | |
| PLENARY SESSION II Current Innovations in the Management of Unique Liver Diseases Moderators: Dr. Tamneet Basra , Caroline Simon, MD, Andres Duchini, MD | ||
| 9:35 AM | State of the Art Lecture II Genetic Liver Diseases in adults (Hemochromatosis, Wilson’s, Alpha-1-antitrypsin deficiency): What do we know in 2024? | Michael Schilsky, MD |
| 10:05 AM | Drug induced Liver Injury- an Update | David E. Bernstein, MD |
| 10:35 AM | Chronic Viral Hepatitis B: Can we expect a Cure? | W. Ray Kim, MD |
| 11:05 AM | Chronic Viral Hepatitis C Elimination: Obstacles & Opportunities | Norah A. Terrault, MD |
| 11:35 AM | Q&A and Discussion | |
| 11:50 AM | LUNCH & PRODUCT THEATRE MASLD: An Overview | Mazen Nourreddin, MD, MHSc |
| PLENARY SESSION III Metabolic Dysfunction-Associated Fatty liver Disease (MASLD)- What is New ? Moderators: Victor Ankoma-Sey, MD, David Victor, MD & Constance Mobley, MD | ||
| 12:50 PM | Metabolic Dysfunction-Associated Fatty liver Disease (MASLD): The New Nomenclature and its implications | Mary Rinella, MD |
| 1:20 PM | Practical Use of Noninvasive Tests in the Diagnosis & Management of MASLD patients | Naim Alkhouri, MD, FAASLD |
| 1:50 PM | State of the Art Lecture III Current and Future Treatment Options in MASLD | TBD |
| 2:20 PM | Role of Artificial Intelligence (AI) in the Management of MASLD? | Vlad Ratziu, MD |
| 2:50 PM | Q&A and Discussion | |
| 3:05 PM | BREAK | |
| PLENARY SESSION IV Liver Cancers: Hepatocellular Carcinoma & Cholangiocarcinoma - Current Concepts & Controversies Moderators: Sudha Kodali, MD, MSPH, Maen Abdelrahim, MD, PhD, B Pharm & Kirk Heyne, MD | ||
| 3:20 PM | Evolving Epidemiology of Hepatocellular Cancer & Cholangiocarcinoma? | Amit Singal, MD |
| 3:50 PM | State of the Art Lecture IV Management of Hepatocellular carcinoma & Cholangiocarcinoma - Role of immunotherapy & Ablative Therapies | Ahmed Kaseb, MD |
| 4:20 PM | Liver Transplantation for Hepatocellular Cancer & Cholangiocarcinoma – Current Approach & Controversies | Sudha Kodali, MD |
| 4:45 PM | Q&A and Discussion | |
| 5:00 PM | CONCLUDING REMARKS | |
We gratefully acknowledge the following companies for supporting our Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2023:
Product Theatre Sponsor: Madrigal Pharmaceuticals
Breakfast Sponsor: Gilead Sciences, Inc.
Exhibitors:
Astellas Pharma Inc.
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.
Madrigal Pharmaceuticals
Mallinckrodt Pharmaceuticals
Merck
Mirum Pharmaceuticals, Inc.
Phathom Pharmaceuticals
Salix Pharmaceuticals
Sirtex
Registration Instructions
- STEP 1 - Select the applicable fee and add to cart to complete the checkout process.
- STEP 2 - Once registered, on the week of the conference you will receive an email from Annie ([email protected]) for more details on exhibiting.